Cornell Pochily Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $775K | Sell |
13,451
-233
| -2% | -$13.4K | 0.21% | 95 |
|
|
2026
Q1 | $830K | Sell |
13,684
-288
| -2% | -$16.8K | 0.24% | 87 |
|
|
2025
Q4 | $754K | Sell |
13,972
-337
| -2% | -$16.2K | 0.22% | 90 |
|
|
2025
Q3 | $645K | Sell |
14,309
-1,027
| -7% | -$48K | 0.19% | 103 |
|
|
2025
Q2 | $710K | Buy |
15,336
+150
| +1% | +$7.36K | 0.23% | 97 |
|
|
2025
Q1 | $926K | Buy |
15,186
+30
| +0.2% | +$1.75K | 0.33% | 78 |
|
|
2024
Q4 | $857K | Buy |
15,156
+858
| +6% | +$47.9K | 0.3% | 82 |
|
|
2024
Q3 | $740K | Buy |
14,298
+285
| +2% | +$13.4K | 0.26% | 92 |
|
|
2024
Q2 | $582K | Buy |
14,013
+2,958
| +27% | +$132K | 0.22% | 103 |
|
|
2024
Q1 | $599K | Sell |
11,055
-718
| -6% | -$36.6K | 0.24% | 102 |
|
|
2023
Q4 | $604K | Sell |
11,773
-973
| -8% | -$51.1K | 0.25% | 100 |
|
|
2023
Q3 | $740K | Buy |
12,746
+8,471
| +198% | +$519K | 0.32% | 85 |
|
|
2023
Q2 | $825K | Sell |
4,275
-8,636
| -67% | -$579K | 0.34% | 82 |
|
|
2023
Q1 | $895K | Buy |
12,911
+62
| +0.5% | +$4.37K | 0.38% | 77 |
|
|
2022
Q4 | $925K | Sell |
12,849
-537
| -4% | -$40.5K | 0.41% | 75 |
|
|
2022
Q3 | $952K | Sell |
13,386
-5,026
| -27% | -$365K | 0.42% | 67 |
|
|
2022
Q2 | $1.42M | Sell |
18,412
-378
| -2% | -$28.8K | 0.63% | 47 |
|
|
2022
Q1 | $1.37M | Buy |
18,790
+698
| +4% | +$46.9K | 0.53% | 53 |
|
|
2021
Q4 | $1.13M | Buy |
18,092
+744
| +4% | +$43.6K | 0.44% | 65 |
|
|
2021
Q3 | $1.03M | Sell |
17,348
-230
| -1% | -$15.1K | 0.44% | 64 |
|
|
2021
Q2 | $1.18M | Buy |
17,578
+872
| +5% | +$56.9K | 0.52% | 52 |
|
|
2021
Q1 | $1.05M | Buy |
16,706
+362
| +2% | +$22.5K | 0.51% | 52 |
|
|
2020
Q4 | $1.01M | Buy |
16,344
+776
| +5% | +$47.7K | 0.49% | 56 |
|
|
2020
Q3 | $939K | Buy |
15,568
+477
| +3% | +$28.7K | 0.54% | 51 |
|
|
2020
Q2 | $887K | Buy |
15,091
+805
| +6% | +$48.1K | 0.55% | 50 |
|
|
2020
Q1 | $796K | Sell |
14,286
-80
| -0.6% | -$4.89K | 0.59% | 51 |
|
|
2019
Q4 | $922K | Buy |
14,366
+2,858
| +25% | +$164K | 0.55% | 51 |
|
|
2019
Q3 | $584K | Sell |
11,508
-837
| -7% | -$39.3K | 0.37% | 80 |
|
|
2019
Q2 | $560K | Buy |
12,345
+1,727
| +16% | +$80.4K | 0.14% | 84 |
|
|
2019
Q1 | $506K | Sell |
10,618
-332
| -3% | -$16.5K | 0.35% | 77 |
|
|
2018
Q4 | $569K | Buy |
10,950
+553
| +5% | +$29.7K | 0.37% | 73 |
|
|
2018
Q3 | $645K | Sell |
10,397
-1,113
| -10% | -$66K | 0.44% | 67 |
|
|
2018
Q2 | $636K | Sell |
11,510
-1,801
| -14% | -$97.3K | 0.44% | 65 |
|
|
2018
Q1 | $841K | Sell |
13,311
-1,664
| -11% | -$107K | 0.6% | 53 |
|
|
2017
Q4 | $917K | Buy |
+14,975
| New | +$937K | 0.59% | 50 |
|
Other funds holding BMY
Cornell Pochily Investment Advisors's BMY Position: Q2 2026 in Review
Cornell Pochily Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $13.4K and leaving 13,451 shares worth $775K. The position accounts for 0.21% of the portfolio, ranked #95.
Cornell Pochily Investment Advisors first reported a position in BMY in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.42M in Q2 2022. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cornell Pochily Investment Advisors held 13,451 shares of Bristol-Myers Squibb worth $775K as of Q2 2026.
- Cornell Pochily Investment Advisors sold 233 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.4K.
- Bristol-Myers Squibb made up 0.21% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #95 holding.
- Cornell Pochily Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 35 quarters since.
- Cornell Pochily Investment Advisors's Bristol-Myers Squibb position peaked at $1.42M in Q2 2022.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.